Literature DB >> 24647842

Cancer cell resistance mechanisms: a mini review.

S Al-Dimassi1, T Abou-Antoun, M El-Sibai.   

Abstract

Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mechanisms developed by cancer cells to resist therapy as well as some of the structures involved such as the ABC members' involvement in chemotherapy resistance and MET and survivin overexpression leading to radiotherapy resistance. Understanding those mechanisms will enable scientists to overcome resistance and possibly improve treatment and disease prognosis.

Entities:  

Mesh:

Year:  2014        PMID: 24647842     DOI: 10.1007/s12094-014-1162-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  39 in total

Review 1.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

Review 2.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; A Rzhetsky; R Allikmets
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 3.  Transport proteins of the ABC family and multidrug resistance of tumor cells.

Authors:  A A Stavrovskaya; T P Stromskaya
Journal:  Biochemistry (Mosc)       Date:  2008-05       Impact factor: 2.487

4.  Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines.

Authors:  Robert O Dillman; Gary B Fogel; Andrew N Cornforth; Senthamil R Selvan; Patric M Schiltz; Carol DePriest
Journal:  Cancer Biother Radiopharm       Date:  2011-08-03       Impact factor: 3.099

5.  Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2005-05-11       Impact factor: 4.009

Review 6.  Structure, function, and evolution of bacterial ATP-binding cassette systems.

Authors:  Amy L Davidson; Elie Dassa; Cedric Orelle; Jue Chen
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

Review 7.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 8.  Current developments in cancer vaccines and cellular immunotherapy.

Authors:  Antoni Ribas; Lisa H Butterfield; John A Glaspy; James S Economou
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

Review 9.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

10.  Identification and bioinformatic characterization of a multidrug resistance associated protein (ABCC) gene in Plasmodium berghei.

Authors:  María González-Pons; Ada C Szeto; Ricardo González-Méndez; Adelfa E Serrano
Journal:  Malar J       Date:  2009-01-02       Impact factor: 2.979

View more
  18 in total

Review 1.  Tumorigenesis: it takes a village.

Authors:  Doris P Tabassum; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2015-07-02       Impact factor: 60.716

Review 2.  Capacity of gold nanoparticles in cancer radiotherapy.

Authors:  Nadeem M S Nagi; Yasir A M Khair; Ahmed M E Abdalla
Journal:  Jpn J Radiol       Date:  2017-08-09       Impact factor: 2.374

3.  miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.

Authors:  Xiaojie Xu; Shuai Jin; Yongfu Ma; Zhongyi Fan; Zhifeng Yan; Wenchao Li; Qi Song; Wenye You; Zhaohui Lyu; Yeqiong Song; Pingan Shi; Ying Liu; Xiao Han; Ling Li; Ying Li; Yang Liu; Qinong Ye
Journal:  J Mol Med (Berl)       Date:  2017-05-09       Impact factor: 4.599

4.  Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ramy Ashry; Ghada Abu Elghanam; Hieu M Pham; Xinyun Su; Camille Stegen; Simon D Tran
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

5.  Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative.

Authors:  Shumin Zhang; Lajos Gera; Kenza Mamouni; Xin Li; Zhengjia Chen; Omer Kucuk; Daqing Wu
Journal:  Oncotarget       Date:  2016-05-10

Review 6.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

Review 7.  Application of nanotechnology to cancer radiotherapy.

Authors:  Yu Mi; Zhiying Shao; Johnny Vang; Orit Kaidar-Person; Andrew Z Wang
Journal:  Cancer Nanotechnol       Date:  2016-12-19

8.  MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression.

Authors:  Z Fan; H Cui; H Yu; Q Ji; L Kang; B Han; J Wang; Q Dong; Y Li; Z Yan; X Yan; X Zhang; Z Lin; Y Hu; S Jiao
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 9.  Bioabsorbable polymers in cancer therapy: latest developments.

Authors:  Ana C Fonseca; Arménio C Serra; Jorge F J Coelho
Journal:  EPMA J       Date:  2015-11-19       Impact factor: 6.543

10.  BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage.

Authors:  Katja Storch; Ellen Dickreuter; Anna Artati; Jerzy Adamski; Nils Cordes
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.